Download to read offline
Uploaded byBadalona Serveis Assistencials
Presentació "Beyond the Pilot: Scaling XR in Real-World Clinical Settings"
Document que va acompanyar la intervenció del panel d'experts que va parlar el 8 de desembre de 2025 a United XR Europe-Stereopsia sobre com assegurar la supervivència dels projectes de realitat ampliada més enllà de la recerca i com fer que formin part de la pràctica clínica real. El metge d'Innovació de Badalona Serveis Assistencials José Ferrer era un dels components del panel. L'esdeveniment United XR Europe-Stereopsia es va celebrar a Brusel·les.
More Related Content
Similar to Presentació "Beyond the Pilot: Scaling XR in Real-World Clinical Settings"
More from Badalona Serveis Assistencials
Presentació "Beyond the Pilot: Scaling XR in Real-World Clinical Settings"
- 1. Healthcare, Pharma &Wellbeing | Dec 8 , 2025 th PANEL Beyond the Pilot: Scaling XR in Real-World Clinical Settings
- 2. Our Speakers José FerrerCosta Medical Researcher Project Manager Badalona Serveis Assistencials U. Oberta de Catalunya Rosemarie De La Cruz Bernabe Professor of Research Ethics and Research Integrity Faculty of Medicine of Oslo Valentino Megale CEO Softcare Studios Gabriel Cerra CEO Immersive Oasis
- 3. ~30 % averageannual growth in clinical investigations with VR/AR terms over the last decade Europe’s flagship project (VR Health Champions) backing XR-healthcare SMEs via €7.8 m to accelerate market readiness Clinical trials using VR on ClinicalTrials.gov (2023) Publications indexed in Pubmed for VR
- 4.
- 5. Why XR Strugglesto Take Root Fragmented workflows Change-management barriers Safety/Security concerns Workforce scarcity Technical Debt “Epidemic of PoC“
- 6. “From PoCs toMVPs” Sanofi's Chief Digital Officer Emmanuel Frenehard
- 7.
- 9. Health systems canand do adapt when the technology is: Mature enough – I’ll come back to this later! Trustworthy enough Valuable enough for patient outcomes Designed with patients’ constraints in mind Supported by robust governance and accountability Clear in its regulatory and ethical profile
- 10. Maturity matters, butit’s probably not the biggest issue. After all, many medical devices do enter clinical practice while still evolving: e.g.,laparoscopic tools, surgical robots, early imaging modalities, pulse oximeters, infusion pumps, etc.
- 12. From an ethicalperspective... If we want XR to move beyond pilots and become truly ubiquitous in healthcare, we must shift the burden of adaptation away from overstretched clinical systems and back onto the ethical responsibilities of XR developers and providers. Ubiquity will not come from more proof-of-concepts, but from technologies that are ethically grounded, transparent by design, clinically meaningful, inclusive, and respectful of autonomy, privacy, identity, and dignity. When XR supports—rather than disrupts—clinical judgment, workflows, and the rights of patients, adoption will follow.
- 13. The Real Challenge Adoptionis Multidimensional NASSS: complexity, organisational fit COM-B Capability, motivation, perception TAM perceived usefulness, ease of use RATE-XR XR safety, usability, ethical requirements MCDA-XR practical adoption criteria built from these frameworks:
- 14. Let’s Prioritize Together We’ll explorewhich criteria this audience considers most critical for scaling XR Part 1: Human and Experience Factors Part 2: Organizational Readiness Part 3: Validation & Governance
- 15.
- 16. Safety and comfort Usabilityand technical reliability Training requirements Patient acceptability and trust Part 1: Human and Experience Factors Which factor matters most for front-line use?
- 17. Workflow integration Institutional andtechnical support Resources and cost Part 2: Organizational Readiness Which factor is the biggest organisational barrier?
- 18. Clinical relevance Evidence andcredibility Legal and ethical alignment Part 3 – Validation & Governance Which factor is most often underestimated?
- 19. Part 1: Human andExperience Factors Part 2: Organizational Readiness Part 3: Validation & Governance Among the three groups, which drives adoption the most?
- 20. Thank You! José FerrerCosta Medical Researcher Project Manager Badalona Serveis Assistencials U. Oberta de Catalunya Rosemarie De La Cruz Bernabe Professor of Research Ethics and Research Integrity Faculty of Medicine of Oslo Valentino Megale CEO Softcare Studios Gabriel Cerra CEO Immersive Oasis